363 related articles for article (PubMed ID: 10525558)
1. An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting.
Rutten-van Mölken M; Roos B; Van Noord JA
Thorax; 1999 Nov; 54(11):995-1003. PubMed ID: 10525558
[TBL] [Abstract][Full Text] [Related]
2. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
Jarvis B; Markham A
Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
[TBL] [Abstract][Full Text] [Related]
3. French-Canadian version of the Chronic Respiratory and St George's Respiratory questionnaires: an assessment of their psychometric properties in patients with chronic obstructive pulmonary disease.
Bourbeau J; Maltais F; Rouleau M; Guímont C
Can Respir J; 2004 Oct; 11(7):480-6. PubMed ID: 15505701
[TBL] [Abstract][Full Text] [Related]
4. American translation, modification, and validation of the St. George's Respiratory Questionnaire.
Barr JT; Schumacher GE; Freeman S; LeMoine M; Bakst AW; Jones PW
Clin Ther; 2000 Sep; 22(9):1121-45. PubMed ID: 11048909
[TBL] [Abstract][Full Text] [Related]
5. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease.
Hajiro T; Nishimura K; Tsukino M; Ikeda A; Koyama H; Izumi T
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):785-90. PubMed ID: 9517591
[TBL] [Abstract][Full Text] [Related]
6. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
Appleton S; Smith B; Veale A; Bara A
Cochrane Database Syst Rev; 2000; (2):CD001104. PubMed ID: 10796594
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the minimal important difference for the feeling thermometer and the St. George's Respiratory Questionnaire in patients with chronic airflow obstruction.
Schünemann HJ; Griffith L; Jaeschke R; Goldstein R; Stubbing D; Guyatt GH
J Clin Epidemiol; 2003 Dec; 56(12):1170-6. PubMed ID: 14680667
[TBL] [Abstract][Full Text] [Related]
8. A novel, short, and simple questionnaire to measure health-related quality of life in patients with chronic obstructive pulmonary disease.
Hajiro T; Nishimura K; Jones PW; Tsukino M; Ikeda A; Koyama H; Izumi T
Am J Respir Crit Care Med; 1999 Jun; 159(6):1874-8. PubMed ID: 10351933
[TBL] [Abstract][Full Text] [Related]
9. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.
Farne HA; Cates CJ
Cochrane Database Syst Rev; 2015 Oct; (10):CD008989. PubMed ID: 26490945
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and safety of combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation twice daily via accuhaler in Chinese patients with COPD.
Zheng JP; Yang L; Wu YM; Chen P; Wen ZG; Huang WJ; Shi Y; Wang CZ; Huang SG; Sun TY; Wang GF; Xiong SD; Zhong NS
Chest; 2007 Dec; 132(6):1756-63. PubMed ID: 17951625
[TBL] [Abstract][Full Text] [Related]
11. Relative responsiveness of the Chronic Respiratory Questionnaire, St. Georges Respiratory Questionnaire and four other health-related quality of life instruments for patients with chronic lung disease.
Puhan MA; Guyatt GH; Goldstein R; Mador J; McKim D; Stahl E; Griffith L; Schünemann HJ
Respir Med; 2007 Feb; 101(2):308-16. PubMed ID: 16782320
[TBL] [Abstract][Full Text] [Related]
12. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
[TBL] [Abstract][Full Text] [Related]
13. Quality of life changes in COPD patients treated with salmeterol.
Jones PW; Bosh TK
Am J Respir Crit Care Med; 1997 Apr; 155(4):1283-9. PubMed ID: 9105068
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the psychometric properties of the St George's Respiratory Questionnaire in patients with severe asthma.
Nelsen LM; Vernon M; Ortega H; Cockle SM; Yancey SW; Brusselle G; Albers FC; Jones PW
Respir Med; 2017 Jul; 128():42-49. PubMed ID: 28610668
[TBL] [Abstract][Full Text] [Related]
15. Reliability and validity of a Swedish version of the St George's Respiratory Questionnaire.
Engström CP; Persson LO; Larsson S; Sullivan M
Eur Respir J; 1998 Jan; 11(1):61-6. PubMed ID: 9543271
[TBL] [Abstract][Full Text] [Related]
16. Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD.
Brusasco V; Hodder R; Miravitlles M; Korducki L; Towse L; Kesten S
Thorax; 2003 May; 58(5):399-404. PubMed ID: 12728159
[TBL] [Abstract][Full Text] [Related]
17. The COPD assessment test and St George's Respiratory Questionnaire: are they equivalent in subjects with COPD?
Morishita-Katsu M; Nishimura K; Taniguchi H; Kimura T; Kondoh Y; Kataoka K; Ogawa T; Watanabe F; Arizono S; Nishiyama O; Nakayasu K; Imaizumi K; Hasegawa Y
Int J Chron Obstruct Pulmon Dis; 2016; 11():1543-51. PubMed ID: 27462150
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy and safety of transdermal tulobuterol in the treatment of stable COPD: an open-label comparison with inhaled salmeterol.
Fukuchi Y; Nagai A; Seyama K; Nishimura M; Hirata K; Kubo K; Ichinose M; Aizawa H;
Treat Respir Med; 2005; 4(6):447-55. PubMed ID: 16336029
[TBL] [Abstract][Full Text] [Related]
19. Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium.
van Noord JA; de Munck DR; Bantje TA; Hop WC; Akveld ML; Bommer AM
Eur Respir J; 2000 May; 15(5):878-85. PubMed ID: 10853852
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of a linear analog scale questionnaire to measure health-related quality of life in elderly patients with chronic obstructive pulmonary disease.
Katsura H; Yamada K; Kida K
J Am Geriatr Soc; 2003 Aug; 51(8):1131-5. PubMed ID: 12890078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
